Brief: Gubra, Boehringer Ingelheim Sign Partnership On Obesity Treatment

Gubra A/S

14/12/2023 07:34

Dec 14 (Reuters) - Gubra A/S  GUBRA.CO :
    * SAID ON WEDNESDAY GUBRA AND BOEHRINGER INGELHEIM SIGN 4TH
PARTNERSHIP ON OBESITY TREATMENT DISCOVERY 
    * NEW RESEARCH AND LICENSE AGREEMENT TO DISCOVER NOVEL
PEPTIDES
FOR THE TREATMENT OF OBESITY
    * UNDER THE AGREEMENT, GUBRA MAY RECEIVE UP TO EUR 144
MILLION
COMPRISING OF UPFRONT, SUCCESS-BASED DEVELOPMENT AND
COMMERCIALIZATION MILESTONES PLUS LOW SINGLE-DIGIT ROYALTIES ON
WORLDWIDE NET SALES

        
 Source text for Eikon:  ID:nMFN1pVGdM 
 Further company coverage:  GUBRA.CO  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))